Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
Adenovirus Infection
Interventions
DRUG

Brincidofovir

BCV administered twice weekly, dose depending on weight.

Trial Locations (33)

10065

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medical College/ New York Presbyterian Hospital, New York

10467

Montifore Medical Center, The Bronx

15224

Children's Hospital of Pittsburgh, Pittsburgh

19024

Fred Hutchingson Cancer Center, Seattle

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Health System, Washington D.C.

21231

Johns Hopkins University, Baltimore

27712

Duke University Medical Center, Durham

28203

Levine Children's Hospital, Charlotte

30322

Children's Healthcare of Atlanta, Aflac Cancer and Blood Center, Atlanta

38105

St. Jude Children's Hospital, Memphis

45229

Cincinnati Children's Hospital, Cincinnati

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

60637

University of Chicago, Chicago

63110

Washington University School of Medicine, St Louis

64108

Children's Mercy Hospital, Kansas City

68198

University of Nebraska, Omaha

70118

Children's Hospital, New Orleans

76104

Cook Children's Medical Center, Fort Worth

77030

Baylor College of Medicine, Houston

MD Anderson Cancer Center, Houston

80045

Children's Hospital Colorado, Aurora

84103

Intermountain Healthcare Research, Salt Lake City

84112

University of Utah Huntsman Cancer Institute, Salt Lake City

85016

Phoenix Children's Hospital, Phoenix

90027

Children's Hospital Los Angeles, Los Angeles

94305

Stanford Children's Hospital, Palo Alto

Stanford University, Stanford

98105

Seattle Children's Hospital, Seattle

02115

Brigham and Woman's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Jazz Pharmaceuticals

INDUSTRY